Despite some issues with availability, data from the U.S. Centers for Disease Control and Prevention show most people are receiving the second dose of the COVID vaccine on time. But some people are reporting more serious side effects with the second dose. One University of Arizona expert says that means the vaccine is working.

A University of Arizona Health Sciences study that is examining COVID-19 immunity and re-infection among frontline workers is expanding to include some Arizona college students while broadening its research focus to include COVID-19 vaccination effectiveness.

The significant role and impact of structural racism needs to be considered in racial and ethnic health-disparities research, say the editors of the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes. Khadijah K. Breathett, MD, assistant professor in the Division of Cardiology at the University of Arizona College of Medicine – Tucson and associate editor of the journal, co-authored the statement.

As a state site, it will eventually be able to operate 24/7 and serve up to 6,000 people per day.

The Arizona Rural EMS Advanced Telemedicine Demonstration Initiative gives rural EMS providers a real-time connection to emergency physicians.

Arizona Rural EMS Advanced Telemedicine Demonstration Initiative aims to improve patient outcomes by expanding EMS access to potentially lifesaving care.

David Beyda, chair and professor in the Department of Bioethics and Medical Humanism at the University of Arizona College of Medicine - Phoenix, discusses the ethics related to the COVID-19 vaccinations.

The past two flu seasons were the worst the state has ever seen, but this season has seen a 93% decrease in the number of cases and is one of the lowest on record – all likely due to COVID-19. "It's a dominant organism in the community. When one virus becomes the dominant organism in the community, it doesn't let other viruses take hold and gain a foothold," said Dr. Shad Marvasti, director of public health, prevention and health promotion at the University of Arizona College of Medicine – Phoenix.

A University of Arizona Health Sciences study has estimated total lifetime costs at $736 million for the 10,359 valley fever patients diagnosed in Arizona in 2019, underscoring the economic burden the disease places on the state and its residents.